Literature DB >> 11034997

Hyperoxia inhibits oxidant-induced apoptosis in lung epithelial cells.

W R Franek1, S Horowitz, L Stansberry, J A Kazzaz, H C Koo, Y Li, Y Arita, J M Davis, A S Mantell, W Scott, L L Mantell.   

Abstract

It has previously been shown that hyperoxia induces nonapoptotic cell death in cultured lung epithelial cells, whereas hydrogen peroxide (H(2)O(2)) and paraquat cause apoptosis. To test whether pathways leading to oxidative apoptosis in epithelial cells are sensitive to molecular O(2), A549 cells were exposed to 95% O(2) prior to exposure to lethal concentrations of H(2)O(2). The extent of H(2)O(2)-induced apoptosis was significantly reduced in cells preexposed to hyperoxia compared with room-air controls. Preexposure of the hyperoxia-resistant HeLa-80 cell line to 80% O(2) also inhibited oxidant-induced apoptosis, suggesting that this inhibition is not due to O(2) toxicity. Because hyperoxia generates reactive oxygen species and activates the redox-sensitive transcription factor nuclear factor kappa B (NF-kappa B), the role of antioxidant enzymes and NF-kappa B were examined in this inhibitory process. The onset of inhibition appeared to be directly related to the degradation of I kappa B and subsequent activation of NF-kappa B (either by hyperoxia or TNF-alpha), whereas no significant up-regulation of endogenous antioxidant enzyme activities was found. In addition, suppression of NF-kappa B activities by transfecting A549 cells with a dominant-negative mutant construct of I kappa B significantly augmented the extent of H(2)O(2)-induced apoptosis. These data suggest that hyperoxia inhibits oxidant-induced apoptosis and that this inhibition is mediated by NF-kappa B.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11034997     DOI: 10.1074/jbc.M004716200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Caveolin-1: a critical regulator of lung injury.

Authors:  Yang Jin; Seon-Jin Lee; Richard D Minshall; Augustine M K Choi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-11-19       Impact factor: 5.464

Review 2.  The pharmokinetic limitations of antioxidant treatment for COPD.

Authors:  Robert Foronjy; Alison Wallace; Jeanine D'Armiento
Journal:  Pulm Pharmacol Ther       Date:  2007-10-23       Impact factor: 3.410

3.  Hyperoxia-induced NF-kappaB activation occurs via a maturationally sensitive atypical pathway.

Authors:  Clyde J Wright; Tiangang Zhuang; Ping La; Guang Yang; Phyllis A Dennery
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-12-12       Impact factor: 5.464

4.  Sustained hyperoxia-induced NF-κB activation improves survival and preserves lung development in neonatal mice.

Authors:  Sarah McKenna; Katherine A Michaelis; Fadeke Agboke; Thanh Liu; Kristie Han; Guang Yang; Phyllis A Dennery; Clyde J Wright
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-04-18       Impact factor: 5.464

5.  Preconditioning mesenchymal stem cells with caspase inhibition and hyperoxia prior to hypoxia exposure increases cell proliferation.

Authors:  Uksha Saini; Richard J Gumina; Brian Wolfe; M Lakshmi Kuppusamy; Periannan Kuppusamy; Konstantinos Dean Boudoulas
Journal:  J Cell Biochem       Date:  2013-11       Impact factor: 4.429

6.  Inhaled ethyl nitrite prevents hyperoxia-impaired postnatal alveolar development in newborn rats.

Authors:  Richard L Auten; Stanley N Mason; Mary H Whorton; William R Lampe; W Michael Foster; Ronald N Goldberg; Bo Li; Jonathan S Stamler; Kathryn M Auten
Journal:  Am J Respir Crit Care Med       Date:  2007-05-03       Impact factor: 21.405

Review 7.  Manipulation of gene expression by oxygen: a primer from bedside to bench.

Authors:  Clyde J Wright; Phyllis A Dennery
Journal:  Pediatr Res       Date:  2009-07       Impact factor: 3.756

8.  The compromise of macrophage functions by hyperoxia is attenuated by ethacrynic acid via inhibition of NF-κB-mediated release of high-mobility group box-1.

Authors:  Mao Wang; Samir Gorasiya; Daniel J Antoine; Ravikumar A Sitapara; Wenjun Wu; Lokesh Sharma; Huan Yang; Charles R Ashby; Divya Vasudevan; Michelle Zur; Douglas D Thomas; Lin L Mantell
Journal:  Am J Respir Cell Mol Biol       Date:  2015-02       Impact factor: 6.914

9.  Maturational differences in lung NF-kappaB activation and their role in tolerance to hyperoxia.

Authors:  Guang Yang; Aida Abate; Adia G George; Yi-Hao Weng; Phyllis A Dennery
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

10.  IκBβ-mediated NF-κB activation confers protection against hyperoxic lung injury.

Authors:  Katherine A Michaelis; Fadeke Agboke; Thanh Liu; Kristie Han; Manasa Muthu; Csaba Galambos; Guang Yang; Phyllis A Dennery; Clyde J Wright
Journal:  Am J Respir Cell Mol Biol       Date:  2014-02       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.